February 27, 2023

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

February 23, 2023

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

February 15, 2023

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

February 15, 2023

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

February 10, 2023

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

February 9, 2023

The application period is now open for Spring Meeting Attendance Awards for minority trainees

February 6, 2023

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

February 1, 2023

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

January 30, 2023

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

ECOG-ACRIN Cancer Research Group